Publication | Closed Access
Characterization of a platelet derived factor modulating phagocyte functions and cooperating with interleukin 1.
13
Citations
0
References
1989
Year
ImmunologyImmunologic MechanismAntigen ProcessingInnate ImmunityImmune SystemImmunotherapyPhagocyte FunctionsInflammationRelease ProteinAutoantibodiesImmune MediatorAllergyAutoimmune DiseaseInterleukin 1AutoimmunityImmune FunctionCell BiologyPhagocytePlatelet ActivationThrombopoiesisCytokineBlood PlateletMonoclonal AntibodiesMedicine
During experiments aiming at the generation of monoclonal antibodies against native human interleukin 2 an antibody of different specificity was obtained, recognizing a polypeptide contaminant within the antigen preparation used for immunization. This antigen was shown to represent a release protein from human blood platelets. Amino acid sequence analysis of the immunopurified antigen revealed its identity as beta-thromboglobulin antigen. Depending on the source of antigen (freshly lysed platelets, platelet containing cell culture supernatants) various forms of the polypeptide, differing in the degree of N-terminal truncation, were found. Beta-thromboglobulin antigen preparations differing in peptide composition also had different capacities for modulating spontaneous as well as Fc-receptor dependent chemiluminescence of human monocytes and granulocytes. In contrast to former reports, no mitogenic activity for human dermal fibroblasts was found with beta-TG antigen (CTAP III) alone, but only in combination with human interleukin 1 and heparin, the three molecules acting synergistically. These findings indicate that beta-TG antigen could play a functional role in linking the blood clotting system to the immune system.